|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
US4902502A
(en)
|
1989-01-23 |
1990-02-20 |
Cetus Corporation |
Preparation of a polymer/interleukin-2 conjugate
|
|
US5089261A
(en)
|
1989-01-23 |
1992-02-18 |
Cetus Corporation |
Preparation of a polymer/interleukin-2 conjugate
|
|
ATE120355T1
(de)
|
1990-02-09 |
1995-04-15 |
Univ Jefferson |
Vorrichtung zur sammlung und verarbeitung von fetten geweben zur herstellung von endothel- zellprodukt.
|
|
GB2285446B
(en)
|
1994-01-03 |
1999-07-28 |
Genentech Inc |
Thrombopoietin
|
|
US5498599A
(en)
|
1994-01-21 |
1996-03-12 |
Amgen Inc. |
Methods for stimulating platelet production
|
|
EP1867720A3
(en)
|
1994-12-02 |
2008-01-09 |
Schering Corporation |
Purified genes encoding mammalian cell surface antigens; proteins and antibodies
|
|
WO1999023199A1
(en)
*
|
1997-10-31 |
1999-05-14 |
Baxter International Inc. |
Closed system for processing primary tissue
|
|
ES2373406T3
(es)
|
1997-12-22 |
2012-02-03 |
Oxford Biomedica (Uk) Limited |
Vectores basados en el virus de la anemia infecciosa equina (vaie).
|
|
CN1507357A
(zh)
|
2000-10-31 |
2004-06-23 |
PRҩƷ����˾ |
提高生物活性分子传递的方法和组合物
|
|
KR100930139B1
(ko)
*
|
2001-12-07 |
2009-12-07 |
사이토리 테라퓨틱스, 인크. |
처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US8034334B2
(en)
|
2002-09-06 |
2011-10-11 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
|
|
TW200823237A
(en)
|
2006-08-28 |
2008-06-01 |
Nuvelo Inc |
Antibodies to NTB-A
|
|
ECSP077628A
(es)
|
2007-05-03 |
2008-12-30 |
Smithkline Beechman Corp |
Nueva composición farmacéutica
|
|
US8796241B2
(en)
|
2007-08-29 |
2014-08-05 |
Adam Lubin |
Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase
|
|
AU2010242780B2
(en)
*
|
2009-05-01 |
2016-04-21 |
Puregraft Llc |
Systems, methods and compositions for optimizing tissue and cell enriched grafts
|
|
US8383099B2
(en)
|
2009-08-28 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adoptive cell therapy with young T cells
|
|
EP2510086A4
(en)
|
2009-12-08 |
2013-05-22 |
Wolf Wilson Mfg Corp |
IMPROVED METHODS FOR CELL CULTURES FOR ADOPTIVE CELL THERAPIES
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
US20130115617A1
(en)
|
2009-12-08 |
2013-05-09 |
John R. Wilson |
Methods of cell culture for adoptive cell therapy
|
|
WO2012065086A1
(en)
|
2010-11-12 |
2012-05-18 |
Nektar Therapeutics |
Conjugates of an il-2 moiety and a polymer
|
|
KR20140004174A
(ko)
|
2011-01-18 |
2014-01-10 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
암 치료를 위한 조성물 및 방법
|
|
US20120244133A1
(en)
|
2011-03-22 |
2012-09-27 |
The United States of America, as represented by the Secretary, Department of Health and |
Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
|
|
CA2832540C
(en)
|
2011-04-08 |
2020-09-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
|
|
WO2013070899A1
(en)
|
2011-11-08 |
2013-05-16 |
Auxocell Laboratories, Inc. |
Systems and methods for processing cells
|
|
CA3285826A1
(en)
|
2012-02-22 |
2026-03-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
|
|
EP2850175B1
(en)
|
2012-05-18 |
2020-12-16 |
Wilson Wolf Manufacturing Corporation |
Improved methods of cell culture for adoptive cell therapy
|
|
EP2859093A4
(en)
|
2012-06-11 |
2016-08-17 |
Wolf Wilson Mfg Corp |
IMPROVED METHODS FOR CELL CULTURES FOR ADOPTIVE CELL THERAPIES
|
|
US20140047572A1
(en)
|
2012-08-13 |
2014-02-13 |
University Of Rochester |
Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
|
|
WO2014055657A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
|
BR112015013431A2
(pt)
|
2012-12-12 |
2017-11-14 |
Vasculox Inc |
anticorpos monoclonais ou respectivos fragmentos ligantes de antígenos, composição farmacêutica, e usos de anticorpo monoclonal ou respectivo fragmento ligante de antígenos
|
|
EP3628322A1
(en)
|
2013-03-01 |
2020-04-01 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Cd8+ t cells that also express pd-1 and/or tim-3 for the treatment of cancer
|
|
EP2961415B1
(en)
|
2013-03-01 |
2021-01-06 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Methods of producing enriched populations of tumor-reactive t cells from tumor
|
|
AU2013205148B2
(en)
|
2013-03-14 |
2014-10-30 |
AVITA Medical Americas, LLC |
Systems and methods for tissue processing and preparation of cell suspension therefrom
|
|
ES2932429T3
(es)
|
2013-07-15 |
2023-01-19 |
Us Health |
Métodos de preparación de células T anti-antígeno de virus del papiloma humano
|
|
EP3060581A4
(en)
|
2013-10-25 |
2017-06-07 |
Dana-Farber Cancer Institute, Inc. |
Anti-pd-l1 monoclonal antibodies and fragments thereof
|
|
AU2015214145A1
(en)
|
2014-02-04 |
2016-08-25 |
Kite Pharma. Inc. |
Methods for producing autologous T cells useful to treat B cell malignancies and other cancers and compositions thereof
|
|
US10934346B2
(en)
|
2014-02-14 |
2021-03-02 |
Bellicum Pharmaceuticals, Inc. |
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
|
|
EP3110428A4
(en)
|
2014-02-28 |
2017-11-22 |
Bdbc Sciences Corp. |
A system for tissue manipulation
|
|
MX375379B
(es)
|
2014-05-29 |
2025-03-06 |
Us Health |
Receptores de celulas t anti - papilomavirus 16 e7 humano.
|
|
RU2739770C2
(ru)
|
2014-06-11 |
2020-12-28 |
полибайосепт ГмбХ |
Экспансия лимфоцитов с использованием композиции цитокинов для активной клеточной иммунотерапии
|
|
WO2015188839A2
(en)
|
2014-06-13 |
2015-12-17 |
Immudex Aps |
General detection and isolation of specific cells by binding of labeled molecules
|
|
CN117467603A
(zh)
|
2015-04-27 |
2024-01-30 |
癌症研究技术有限公司 |
治疗癌症的方法
|
|
WO2016179006A1
(en)
|
2015-05-01 |
2016-11-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating t cells and t cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
|
|
WO2017008019A1
(en)
|
2015-07-08 |
2017-01-12 |
The Johns Hopkins University |
Marrow infiltrating lymphocytes (mils) as a source of t-cells for chimeric antigen receptor (car) therapy
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
ES2879287T3
(es)
|
2015-09-15 |
2021-11-22 |
Us Health |
Receptores de células T que reconocen KRAS mutado restringido a HLA-cw8
|
|
WO2017053423A1
(en)
|
2015-09-21 |
2017-03-30 |
Erasmus University Medical Center |
Anti-cd47 antibodies and methods of use
|
|
KR20180063320A
(ko)
|
2015-10-20 |
2018-06-11 |
카이트 파마 인코포레이티드 |
T 세포 요법을 위한 t 세포를 제조하는 방법
|
|
GB201522097D0
(en)
|
2015-12-15 |
2016-01-27 |
Cellular Therapeutics Ltd |
Cells
|
|
WO2017179015A1
(en)
|
2016-04-15 |
2017-10-19 |
Glaxosmithkline Intellectual Property Development Limited |
Compositions for the treatment of cancer
|
|
CR20180551A
(es)
|
2016-04-21 |
2019-02-12 |
Immatics Biotechnologies Gmbh |
Inmunoterapia contra el melanoma y otros tipos de cáncer
|
|
US20190136230A1
(en)
|
2016-05-06 |
2019-05-09 |
Juno Therapeutics, Inc. |
Genetically engineered cells and methods of making the same
|
|
MA45595A
(fr)
*
|
2016-07-07 |
2019-05-15 |
Iovance Biotherapeutics Inc |
Protéines de liaison au ligand (1) de mort programmée (1) (pd-l1) et leurs procédés d'utilisation
|
|
WO2018014039A1
(en)
|
2016-07-15 |
2018-01-18 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors (cars) specific for muc1 and methods for their use
|
|
HRP20221183T1
(hr)
|
2016-08-02 |
2022-12-09 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
T-stanični receptori anti-kras-g12d
|
|
CN110520530A
(zh)
|
2016-10-18 |
2019-11-29 |
明尼苏达大学董事会 |
肿瘤浸润性淋巴细胞和治疗方法
|
|
HUE066460T2
(hu)
|
2016-10-26 |
2024-08-28 |
Iovance Biotherapeutics Inc |
A kriokonzervált tumor infiltráló limfociták restimulációja
|
|
US20190262400A1
(en)
|
2016-10-31 |
2019-08-29 |
H. Lee Moffitt Cancer Center And Research Institure, Inc. |
Artificial antigen presenting cells for expanding immune cells for immunotherapy
|
|
TWI788307B
(zh)
|
2016-10-31 |
2023-01-01 |
美商艾歐凡斯生物治療公司 |
用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
|
|
KR102618948B1
(ko)
|
2016-11-17 |
2023-12-27 |
이오반스 바이오테라퓨틱스, 인크. |
잔유 종양 침윤 림프구 및 그의 제조 및 사용 방법
|
|
MX2019007963A
(es)
|
2017-01-06 |
2019-10-21 |
Iovance Biotherapeutics Inc |
Expansion de linfocitos infiltrantes de tumor (til) con agonistas de la superfamilia de recptor de factor de necrosis tumoral (tnfrsf) y combinaciones terapeuticas de til- y agonistas de tnfrsf.
|
|
CA3049165A1
(en)
|
2017-01-06 |
2018-07-12 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
|
|
GB201700621D0
(en)
|
2017-01-13 |
2017-03-01 |
Guest Ryan Dominic |
Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
|
|
US11254913B1
(en)
|
2017-03-29 |
2022-02-22 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
JOP20190224A1
(ar)
|
2017-03-29 |
2019-09-26 |
Iovance Biotherapeutics Inc |
عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
|
|
CN110612446B
(zh)
|
2017-03-31 |
2023-07-04 |
美国卫生和人力服务部 |
分离新抗原-特异性t细胞受体序列的方法
|
|
KR20200003913A
(ko)
|
2017-05-10 |
2020-01-10 |
이오반스 바이오테라퓨틱스, 인크. |
액상 종양으로부터의 종양 침윤 림프구의 확장 및 그의 치료 용도
|
|
AR112072A1
(es)
|
2017-06-05 |
2019-09-18 |
Iovance Biotherapeutics Inc |
Métodos de uso de linfocitos infiltrantes de tumor en melanoma doble refractario
|
|
KR20250037592A
(ko)
|
2017-09-20 |
2025-03-17 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
돌연변이된 ras에 대한 hla 클래스 ii-제한된 t 세포 수용체
|
|
SG11202002635RA
(en)
|
2017-09-29 |
2020-04-29 |
The United States Of America As Represented By The Secretary |
Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation
|
|
CR20200251A
(es)
|
2017-11-17 |
2020-07-17 |
Iovance Biotherapeutics Inc |
Expansión de til de aspirados con aguja fina y biopsias por punción
|
|
EP3714041A1
(en)
|
2017-11-22 |
2020-09-30 |
Iovance Biotherapeutics, Inc. |
Expansion of peripheral blood lymphocytes (pbls) from peripheral blood
|
|
US20210369775A1
(en)
|
2017-12-15 |
2021-12-02 |
Iovance Biotherapeutics, Inc. |
Systems and methods for determining the beneficial administration of tumor infiltrating lymphocytes, and methods of use thereof and beneficial administration of tumor infiltrating lymphocytes, and methods of use thereof
|
|
WO2019136459A1
(en)
|
2018-01-08 |
2019-07-11 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products enriched for tumor antigen-specific t-cells
|
|
EP3737743A1
(en)
|
2018-01-08 |
2020-11-18 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products enriched for tumor antigen-specific t-cells
|
|
GB201801067D0
(en)
|
2018-01-23 |
2018-03-07 |
Price Nicola Kaye |
Biomarkers predictive of tumour infiltrating lymphocyte therapy and uses thereof
|
|
BR112020016176A2
(pt)
*
|
2018-02-09 |
2022-02-22 |
Immatics Us Inc |
Métodos de transdução de uma célula t, célula t transduzida geneticamente, composição farmacêutica, métodos de preparação de uma população de células t e uso da célula t
|
|
EP3749770B9
(en)
|
2018-02-09 |
2025-12-17 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Tethered interleukin-15 and interleukin-21
|
|
CA3090795A1
(en)
|
2018-02-13 |
2019-08-22 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes (tils) with adenosine a2a receptor antagonists and therapeutic combinations of tils and adenosine a2a receptor antagonists
|
|
CA3094957A1
(en)
|
2018-03-29 |
2019-10-03 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
WO2019210131A1
(en)
*
|
2018-04-27 |
2019-10-31 |
Iovance Biotherapeutics, Inc. |
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
WO2019217753A1
(en)
|
2018-05-10 |
2019-11-14 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
GB201810181D0
(en)
|
2018-06-21 |
2018-08-08 |
Immetacyte Ltd |
Cells expressing chimeric recominant growth factor receptors
|
|
TW202031273A
(zh)
|
2018-08-31 |
2020-09-01 |
美商艾歐凡斯生物治療公司 |
抗ｐｄ－１抗體難治療性之非小細胞肺癌（ｎｓｃｌｃ）病患的治療
|
|
IL281423B2
(en)
|
2018-09-20 |
2024-08-01 |
Iovance Biotherapeutics Inc |
Expansion of TILS from cryopreserved tumor samples
|
|
US12611427B2
(en)
|
2018-11-05 |
2026-04-28 |
Iovance Biotherapeutics, Inc. |
Treatment of NSCLC patients refractory for anti-PD-1 antibody
|
|
MY210603A
(en)
|
2018-11-05 |
2025-10-01 |
Iovance Biotherapeutics Inc |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
JP7854297B2
(ja)
|
2018-11-05 |
2026-05-01 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
改良された腫瘍反応性ｔ細胞の選択
|
|
WO2020096927A1
(en)
|
2018-11-05 |
2020-05-14 |
Iovance Biotherapeutics, Inc. |
Expansion of tils utilizing akt pathway inhibitors
|
|
KR20210125986A
(ko)
|
2018-12-07 |
2021-10-19 |
그라셀 바이오테크놀로지스 (상하이) 컴퍼니, 리미티드 |
면역요법을 위한 조성물 및 방법
|
|
CA3123392A1
(en)
|
2018-12-19 |
2020-06-25 |
Iovance Biotherapeutics, Inc. |
Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof
|
|
WO2020146740A1
(en)
|
2019-01-10 |
2020-07-16 |
Iovance Biotherapeutics, Inc. |
System and methods for monitoring adoptive cell therapy clonality and persistence
|
|
GB201900858D0
(en)
|
2019-01-22 |
2019-03-13 |
Price Nicola Kaye |
Receptors providing targeted costimulation for adoptive cell therapy
|
|
KR102926094B1
(ko)
|
2019-03-01 |
2026-02-12 |
바이오세이프 쏘시에떼아노님 |
폐쇄된 조직 분해 및 냉동 보존
|
|
WO2020180733A1
(en)
|
2019-03-01 |
2020-09-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
|
WO2020232029A1
(en)
|
2019-05-13 |
2020-11-19 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
GB201910605D0
(en)
|
2019-07-24 |
2019-09-04 |
Immetacyte Ltd |
Tumour infltracting lymphocyte therapy amd uses thereo
|
|
EP4048295A1
(en)
|
2019-10-25 |
2022-08-31 |
Iovance Biotherapeutics, Inc. |
Gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
US12516291B2
(en)
|
2019-12-11 |
2026-01-06 |
Iovance Biotherapeutics, Inc. |
Processes for the production of tumor infiltrating lymphocytes (TILs) and methods of using the same
|
|
FR3105367A1
(fr)
|
2019-12-20 |
2021-06-25 |
Valeo Systemes Thermiques |
Module de dispositif de ventilation pour module de refroidissement de véhicule automobile, dispositif de ventilation comportant un tel module et module de refroidissement pour véhicule automobile comprenant un tel dispositif de ventilation
|
|
BR112022011795A2
(pt)
|
2019-12-20 |
2022-08-30 |
Instil Bio Uk Ltd |
Métodos para preparar e isolar uma população terapêutica de linfócitos e para tratar câncer em um indivíduo, população terapêutica de linfócitos, bolsa criopreservada, recipiente flexível, e, sistema para extração de linfócitos
|
|
CN115997008A
(zh)
|
2020-04-22 |
2023-04-21 |
艾欧凡斯生物治疗公司 |
协调用于患者特异性免疫疗法的细胞的制造的系统和方法
|
|
CA3177413A1
(en)
|
2020-05-04 |
2021-11-11 |
Michelle SIMPSON-ABELSON |
Selection of improved tumor reactive t-cells
|
|
CA3176826A1
(en)
|
2020-05-04 |
2021-11-11 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
US20230277670A1
(en)
|
2020-07-17 |
2023-09-07 |
John Bridgeman |
Chimeric molecules providing targeted costimulation for adoptive cell therapy
|
|
EP4182338A1
(en)
|
2020-07-17 |
2023-05-24 |
Instil Bio (Uk) Limited |
Receptors providing targeted costimulation for adoptive cell therapy
|
|
JP2023546359A
(ja)
|
2020-10-06 |
2023-11-02 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
腫瘍浸潤リンパ球療法によるｎｓｃｌｃ患者の治療
|
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
|
US20230392102A1
(en)
|
2020-10-22 |
2023-12-07 |
Iovance Biotherapeutics, Inc. |
Cell culture system and methods of using the same
|
|
EP4259164A1
(en)
|
2020-12-11 |
2023-10-18 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with braf inhibitors and/or mek inhibitors
|
|
EP4262827A1
(en)
|
2020-12-17 |
2023-10-25 |
Iovance Biotherapeutics, Inc. |
Treatment of cancers with tumor infiltrating lymphocytes
|
|
AU2021401302A1
(en)
|
2020-12-17 |
2023-07-06 |
Iovance Biotherapeutics, Inc. |
Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
|
|
EP4263807A2
(en)
|
2020-12-18 |
2023-10-25 |
Instil Bio (Uk) Limited |
Processing of tumor infiltrating lymphocytes
|
|
JP2023554425A
(ja)
|
2020-12-18 |
2023-12-27 |
インスティル バイオ （ユーケイ） リミテッド |
腫瘍浸潤リンパ球の処理
|
|
EP4262828A1
(en)
|
2020-12-18 |
2023-10-25 |
Instil Bio (Uk) Limited |
Tumor infiltrating lymphocytes and anti-cd47 therapeutics
|
|
JP2024501845A
(ja)
|
2020-12-31 |
2024-01-16 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
腫瘍浸潤リンパ球の自動化された産生のためのデバイス及びプロセス
|
|
WO2022165260A1
(en)
|
2021-01-29 |
2022-08-04 |
Iovance Biotherapeutics, Inc. |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|